Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA9144 MiclxinSummary: Miclxin (DS37262926) is a potent inhibitor of mutants involved in signaling pathways. -
BA9149 iCRT-5Summary: iCRT-5 is a regulated transcriptional inhibitor. -
BA9172 BMS-986365Summary: BMS-986365 is a selective heterobifunctional ligand-directed degradation (LDD) agent targeting the androgen receptor. -
BA9185 ARD-266Summary: ARD-266 is a potent androgen receptor (,) degrader based on E3 ligase. -
BA9186 ARD-2128Summary: ARD-2128 is a potent androgen receptor degrader. -
BA9236 SLU-PP-1072Summary: SLU-PP-1072 is a dual inverse agonist for prostate cancer (PCa) research. -
BA9246 MedicarpinSummary: Medicarpin is a flavonoid isolated from alfalfa. -
BA9253 DIM-C-pPhCO2MeSummary: DIM-C-pPhCO2Me is a nuclear receptor 4A1 (NR4A1) antagonist. -
BA9272 PS121912Summary: PS121912 is a selective vitamin D receptor co-regulator inhibitor. -
BA9281 ElocalcitolSummary: Elocalcitol (BXL-628) is a selective, orally active agonist.

